Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 24, 2023
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
[ Tue, Jan 24th 2023
] - WOPRAI
Joshua Spector Upgraded (CC) to Strong Buy and Increased Target to $43 on, Jan 24th, 2023
Joshua Spector of UBS, Upgraded "The Chemours Company" (CC) to Strong Buy and Increased Target from $31 to $43 on, Jan 24th, 2023.
Joshua has made no other calls on CC in the last 4 months.
There are 9 other peers that have a rating on CC. Out of the 9 peers that are also analyzing CC, 6 agree with Joshua's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Arun Viswanathan of "RBC Capital" Downgraded from Buy to Hold and Decreased Target to $33 on, Tuesday, January 10th, 2023
- PJ Juvekar of "Citigroup" Maintained at Hold with Increased Target to $33 on, Thursday, December 15th, 2022
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Decreased Target to $33 on, Tuesday, October 25th, 2022
- Duffy Fischer of "Goldman Sachs" Initiated at Hold and Held Target at $30 on, Thursday, October 13th, 2022
- David Coleman of "Argus Research" Downgraded from Strong Buy to Hold on, Wednesday, October 5th, 2022
- Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $30 on, Tuesday, September 27th, 2022
These are the ratings of the 3 analyists that currently disagree with Joshua
- Matthew DeYoe of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $40 on, Wednesday, January 11th, 2023
- John Roberts of "Credit Suisse" Initiated at Sell and Held Target at $24 on, Tuesday, November 1st, 2022
- John McNulty of "BMO Capital" Maintained at Buy with Decreased Target to $41 on, Thursday, October 27th, 2022
